[Experience with Imposit in the treatment of inflammatory involvements in the oral and pharyngeal area].
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D062365:Aminobenzoates / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001592:Benzyl Alcohols / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use*; D002594:Cetylpyridinium / Q000627:therapeutic use*; D002648:Child; D004338:Drug Combinations; D005260:Female; D006096:Gramicidin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy*; D010608:Pharyngeal Diseases / Q000188:drug therapy*; D011726:Pyridinium Compounds / Q000627:therapeutic use*
D062365:Aminobenzoates; D000893:Anti-Inflammatory Agents; D001592:Benzyl Alcohols; D001593:Benzyl Compounds; D004338:Drug Combinations; D011726:Pyridinium Compounds; D006096:Gramicidin; D002594:Cetylpyridinium
Erfahrungen mit Imposit bei der Behandlung entzündlicher Affektionen im Mund- und Rachenbereich